title: Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses.
abstract: Central dopaminergic (DA) systems are affected during human immunodeficiency virus (HIV) infection. So far, it is believed that they degenerate with progression of HIV disease because deterioration of DA systems is evident in advanced stages of infection. In this manuscript we found that (a) DA levels are increased and DA turnover is decreased in CSF of therapy-naïve HIV patients in asymptomatic infection, (b) DA increase does not modulate the availability of DA transporters and D2-receptors, (c) DA correlates inversely with CD4+ numbers in blood. These findings show activation of central DA systems without development of adaptive responses at DA synapses in asymptomatic HIV infection. It is probable that DA deterioration in advanced stages of HIV infection may derive from increased DA availability in early infection, resulting in DA neurotoxicity. Our findings provide a clue to the synergism between DA medication or drugs of abuse and HIV infection to exacerbate and accelerate HIV neuropsychiatric disease, a central issue in the neurobiology of HIV.
authors.affiliation: Institute of Virology and Immunobiology, University of Würzburg, Versbacherstr. 7, 97078 Würzburg, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Scheller
authors.forename: G
authors.initials: G
authors.lastname: Arendt
authors.forename: T
authors.initials: T
authors.lastname: Nolting
authors.forename: C
authors.initials: C
authors.lastname: Antke
authors.forename: S
authors.initials: S
authors.lastname: Sopper
authors.forename: M
authors.initials: M
authors.lastname: Maschke
authors.forename: M
authors.initials: M
authors.lastname: Obermann
authors.forename: A
authors.initials: A
authors.lastname: Angerer
authors.forename: I W
authors.initials: IW
authors.lastname: Husstedt
authors.forename: F
authors.initials: F
authors.lastname: Meisner
authors.forename: E
authors.initials: E
authors.lastname: Neuen-Jacob
authors.forename: H W
authors.initials: HW
authors.lastname: Müller
authors.forename: P
authors.initials: P
authors.lastname: Carey
authors.forename: V
authors.initials: V
authors.lastname: Ter Meulen
authors.forename: P
authors.initials: P
authors.lastname: Riederer
authors.forename: E
authors.initials: E
authors.lastname: Koutsilieri
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000134:cerebrospinal fluid; D000328:Adult; D001549:Benzamides; D015704:CD4 Antigens / Q000378:metabolism; D016022:Case-Control Studies; D018932:Chemokine CCL2 / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D005695:Galactosephosphates / Q000378:metabolism; D006678:HIV / Q000235:genetics; D015658:HIV Infections / Q000134:cerebrospinal fluid / Q000000981:diagnostic imaging / Q000276:immunology / Q000378:metabolism* / Q000473:pathology*; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D008297:Male; D008875:Middle Aged; D011759:Pyrrolidines; D009435:Synaptic Transmission / Q000502:physiology*; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods; D014326:Tropanes; D019562:Viral Load / Q000379:methods
chemical_list: D001549:Benzamides; C111835:CCL2 protein, human; D015704:CD4 Antigens; D018932:Chemokine CCL2; D005695:Galactosephosphates; D011759:Pyrrolidines; D014326:Tropanes; C097493:galactitol 3-phosphate; D015102:3,4-Dihydroxyphenylacetic Acid; C087552:2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane; C055743:3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide; D004298:Dopamine; D006719:Homovanillic Acid
references.citation: Ann N Y Acad Sci. 2006 Aug;1074:31-41
references.pmid: 17105901
references.citation: Curr HIV Res. 2007 May;5(3):301-13
references.pmid: 17504172
references.citation: Acta Neuropathol. 2004 Mar;107(3):216-26
references.pmid: 14712399
references.citation: J Biol Chem. 2000 Feb 11;275(6):4159-65
references.pmid: 10660577
references.citation: Brain Pathol. 1998 Apr;8(2):277-84
references.pmid: 9546286
references.citation: FASEB J. 2006 Mar;20(3):515-7
references.pmid: 16384912
references.citation: J Nucl Med. 1996 Jul;37(7):1133-41
references.pmid: 8965184
references.citation: J Neurovirol. 2009 Apr;15(2):131-8
references.pmid: 19115126
references.citation: J Neurochem. 2005 Oct;95(2):377-87
references.pmid: 16190867
references.citation: J Neurol. 2009 Jun;256(6):948-53
references.pmid: 19240951
references.citation: Acta Neuropathol. 2001 Feb;101(2):85-91
references.pmid: 11271377
references.citation: J Neurochem. 1984 Jul;43(1):151-9
references.pmid: 6202842
references.citation: J Neurosci Res. 1991 Mar;28(3):406-9
references.pmid: 1856886
references.citation: Neuroreport. 1996 Mar 22;7(4):910-2
references.pmid: 8724671
references.citation: J Neurovirol. 2009 May;15(3):257-74
references.pmid: 19499455
references.citation: J Neurochem. 1995 Feb;64(2):718-23
references.pmid: 7830065
references.citation: Acta Neuropathol. 1990;80(4):393-400
references.pmid: 2239151
references.citation: Intervirology. 1997;40(2-3):122-31
references.pmid: 9450229
references.citation: J Neurovirol. 2004 Jun;10(3):163-70
references.pmid: 15204921
references.citation: J Neurosci. 1999 Feb 15;19(4):1484-91
references.pmid: 9952424
references.citation: J Neural Transm (Vienna). 2002 May;109(5-6):767-75
references.pmid: 12111466
references.citation: AIDS. 1994 Jan;8(1):67-71
references.pmid: 8011238
references.citation: Neuropsychopharmacology. 2008 Aug;33(9):2228-36
references.pmid: 17971830
references.citation: Brain. 2004 Nov;127(Pt 11):2452-8
references.pmid: 15319273
references.citation: Synapse. 2006 Jan;59(1):51-60
references.pmid: 16237680
references.citation: J Neuroimmune Pharmacol. 2006 Dec;1(4):410-20
references.pmid: 18040813
references.citation: J Neural Transm (Vienna). 2001;108(6):767-75
references.pmid: 11478426
references.citation: Neurology. 2001 Jan 23;56(2):278-9
references.pmid: 11160977
references.citation: Acta Neuropathol. 2000 Apr;99(4):376-84
references.pmid: 10787036
references.citation: Neuroreport. 1997 Dec 1;8(17):3833-6
references.pmid: 9427379
references.citation: Clin Neuropharmacol. 2000 Jul-Aug;23(4):190-4
references.pmid: 11020122
references.citation: Neurosci Lett. 2006 Mar 13;395(3):235-9
references.pmid: 16356633